Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 4524
  • Home
  • Print this page
  • Email this page
SYMPOSIUM
Year : 2007  |  Volume : 55  |  Issue : 6  |  Page : 413-415

Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration


Chief-Retina Vitreous Services, Aravind eye Hospital, Madurai, India

Correspondence Address:
Ramasamy Kim
Chief- Retina Vitreous Services, Aravind Eye Hospital, Madurai
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0301-4738.36473

Rights and Permissions

Recent developments may provide an opportunity to improve outcome in individuals who develop neovascular age-related macular degeneration (ARMD). Several therapies have been introduced that show promise for halting the progression of this disorder. However, data from controlled clinical trials to test the relative efficacy of different management strategies across the subtypes of disease remain limited. New treatment modalities that target the neovascularization process, including leakage from choroidal neovascularization (CNV), are currently being developed. Vascular endothelial growth factor (VEGF) has been implicated as a key mediator in the pathogenesis of ARMD-related CNV. Anti-VEGF strategies show promise as potential therapeutic agents for the treatment of CNV and are currently undergoing active clinical investigation. Such strategies include anti-VEGF antibodies, anti-VEGF aptamer, gene therapy and protein kinase C inhibition. This article reviews the mechanism of action and rationale for anti-VEGF drugs in ARMD.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed8207    
    Printed188    
    Emailed6    
    PDF Downloaded1453    
    Comments [Add]    
    Cited by others 8    

Recommend this journal